NYSE:ADNTAdient Stock Price, Forecast & News

Adient's stock was trading at $16.45 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, ADNT shares have increased by 10.9% and is now trading at $18.24.
View which stocks have been most impacted by COVID-19.

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Adient in the last year. There are currently 1 sell rating, 4 hold ratings and 7 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Adient.

Adient is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Adient.

Adient PLC (NYSE:ADNT) issued its quarterly earnings data on Thursday, August, 6th. The company reported ($2.78) EPS for the quarter, missing the Zacks' consensus estimate of ($2.08) by $0.70. The firm had revenue of $1.63 billion for the quarter, compared to analyst estimates of $1.64 billion. Adient had a negative return on equity of 2.80% and a negative net margin of 3.96%. Adient's revenue for the quarter was down 61.5% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.38 EPS.
View Adient's earnings history.

Adient issued an update on its fourth quarter 2020 Pre-Market earnings guidance on Thursday, August, 6th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $3.3-3.5 billion, compared to the consensus revenue estimate of $3.31 billion.

12 Wall Street analysts have issued 12 month price targets for Adient's stock. Their forecasts range from $13.00 to $28.00. On average, they anticipate Adient's share price to reach $21.67 in the next year. This suggests a possible upside of 18.8% from the stock's current price.
View analysts' price targets for Adient.

Headlines about ADNT stock have trended somewhat positive on Saturday, according to InfoTrie Sentiment. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Adient earned a news impact score of 0.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the near term.
View the latest news about Adient.

Adient saw a drop in short interest in June. As of June 15th, there was short interest totaling 3,160,000 shares, a drop of 22.9% from the May 31st total of 4,100,000 shares. Based on an average daily trading volume, of 1,560,000 shares, the short-interest ratio is presently 2.0 days. Approximately 3.4% of the company's shares are short sold.
View Adient's Short Interest.

Some companies that are related to Adient include Dongfeng Motor Group (DNFGY), Allison Transmission (ALSN), LCI Industries (LCII), Dorman Products (DORM), Dana (DAN), Meritor (MTOR), Delphi Technologies (DLPH), Gentherm (THRM), Veoneer (VNE), Standard Motor Products (SMP), American Axle & Manufact. (AXL), Tower International (TOWR), Stoneridge (SRI), Tenneco (TEN) and Garrett Motion (GTX).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Adient investors own include Johnson Controls International (JCI), AT&T (T), AbbVie (ABBV), Exxon Mobil (XOM), Cisco Systems (CSCO), Intel (INTC), Pfizer (PFE), Johnson & Johnson (JNJ), JPMorgan Chase & Co. (JPM) and Verizon Communications (VZ).

Adient trades on the New York Stock Exchange (NYSE) under the ticker symbol "ADNT."

Adient's stock is owned by many different retail and institutional investors. Top institutional investors include Lyrical Asset Management LP (5.55%), Vanguard Group Inc. (3.55%), Goldman Sachs Group Inc. (3.05%), Prudential Financial Inc. (2.38%), Letko Brosseau & Associates Inc. (2.38%) and FMR LLC (2.13%). Company insiders that own Adient stock include Gregory Scott Smith, Jeffrey Stafeil and Jerome J Dorlack.
View institutional ownership trends for Adient.

ADNT stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Vanguard Group Inc., Point72 Asset Management L.P., Letko Brosseau & Associates Inc., SG Americas Securities LLC, Hosking Partners LLP, Trexquant Investment LP, and Caption Management LLC.
View insider buying and selling activity for Adient.

ADNT stock was acquired by a variety of institutional investors in the last quarter, including Lyrical Asset Management LP, Goldman Sachs Group Inc., Impala Asset Management LLC, Hudson Bay Capital Management LP, Prudential Financial Inc., Alyeska Investment Group L.P., Brookfield Asset Management Inc., and Balyasny Asset Management LLC. Company insiders that have bought Adient stock in the last two years include Gregory Scott Smith, Jeffrey Stafeil, and Jerome J Dorlack.
View insider buying and selling activity for Adient.

Shares of ADNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of ADNT stock can currently be purchased for approximately $18.24.

Adient has a market capitalization of $1.71 billion and generates $16.53 billion in revenue each year. The company earns $-491,000,000.00 in net income (profit) each year or $1.63 on an earnings per share basis. Adient employs 83,000 workers across the globe.

The official website for Adient is www.adient.com.

Adient's mailing address is 49200 Halyard Drive, Plymouth MI, 48170. The company can be reached via phone at 734-254-5000.